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THE major epitope (Gala1,3Gal) on pig endothelial 
.1. cells that is recognized by naturally occurring antibod-
ies in humans is a product of an enzyme called a1,3galac-
tosyltransferase (a1,3GT), the gene for which is functional 
in pigs but not in Old World monkeys, apes, and humans.1 
In contrast, the functional analogue of al,3GT in human is 
an enzyme called aI,2fucosyltransfetase (HT), the product 
of which (H-antigen) is expressed on the cell surface.:! 
Using the murine H2Kb promoter construct, transgenic 
mice expressing H-antigen have been produced with rela-
tive ease.3 ,4 However, the same is not true for pigs,5-7 
suggesting that the promoters are distinct in the two 
species. As the first step in clarifying whether any differ-
ences exist in the regulation of the al,3GT gene in the two 
species, we already reported the regulatory regions in pig.8 
Here we report the isolation and characterization of the 
al,3GT gene promoter regions and the total genomic 
organization in mice. 
MATERIALS AND METHODS 
To identify the 5' and 3' ends of al,3GT gene transcripts, 5'- and 
3'-RACE procedures were performed using the Marathon cDNA 
Amplification Kit (Clontech) with the spleen poly A + RNA of 
Balb/C adult male as template. To identify exon-intron boundaries 
or 5'- and 3'-flanking region of the transcripts, Murine Genome-
Walker libraries were constructed using the Universal Genome-
Walker Library Kit (Clontech) with Balb/C genomic DNA. To 
evaluate the promoter activity, we used Dual-Luciferase Reporter 
Assay System (Promega). Fragment of 1280 bp upstream from the 
position -350 (A of start codon is assigned + 1) was cloned into 
multi-cloning site of the luciferase gene of a luciferase reporter 
vector, pGL3-Basic, provided in the kit, termed pGL3/1280. The 
pGL3-Basic (promoter-less) was used for the comparison. 
RESULTS 
Nucleotide sequences of our 5' -RACE are longer by 56 bp 
than previously reported by Joziasse et al.9 The relative 
intensity of luciferase activity by the pGL3/1280 construct 
was IS-fold higher than that of pGL3-Basic. These data 
indicate that the (1280 bp) fragment has promoter activity, 
and that our 5'-RACE result most likely represents the 
potential transcription initiation site (TIS). Our 3' -RACE 
revealed an extended 3'-UTR sequence 30 bp more than 
previously reported,9 but no other 3' UTR exon usage. The 
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overall length of the transcript was 3537 bp, 86 bp longer 
than previously reported.9 
An overall comparison of 5' -UTR of cDNA sequences of 
the al,3GT gene in porcine (675 bp) and murine (501 bp) 
shows that the homology is observed only in the region of 
exon 2 (71.7%). Exon 3 observed in mice is not observed in 
pig. Murine exon 1 shows no homology with porcine exon 1. 
DISCUSSION 
We have identified the regulatory region of the murine and 
porcine in al,3GT gene. The sequence analysis of the 
5' -flanking region of exon 1 revealed that there is no 
homology between the two species. Interestingly, despite 
this divergence, the two species have in common multiple 
GC-box, SPI, AP2, and other consensus motifs without 
TATA-box or CAAT-box immediately upstream of the 
transcription initiation site. However, they differ in that a 
CpG island is observed around TIS of this gene in the 
porcine, but not in the murine, species. 
Taken together, these findings suggest that the regulation 
of al,3GT gene expression may vary between the two 
species even though the enzyme performs an identical 
function. This would have important physiological implica-
tions and provide a possible explanation for the observed 
differences in the expression of the H-antigen in transgenic 
mice and pigs. In general, the genes in vertebrates that have 
a CpG island tend to be transcribed in early stage of cell 
replication. lO Thus, provision of a porcine promoter rather 
than an H2Kb mouse promoter as has been previously 
reported6•7 is likely to be the optimal condition for the 
regulation of a porcine al,3GT gene in the porcine cells or 
tissues of transgenic animals. 
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